The History: From Ivar Sandström to the Sequence of Parathyroid Hormone

  • Michael MannstadtEmail author
  • John T. PottsJr.


The history of the discovery of the parathyroid glands and the evolution of knowledge about parathyroid hormone (PTH) are rewarding for the insights it provides into the basic physiology and pathophysiology of bone and mineral metabolism and the diseases hypoparathyroidism and hyperparathyroidism. The early history illustrates the surprising contradictions and confusion that can occur in scientific investigations along the pathway to a clearer understanding of biology and disease. This chapter will focus on hypoparathyroidism consistent with the theme of this volume.


History of parathyroid glands History of endocrinology Hypoparathyroidism Sandström 


  1. 1.
    Sandström I (1880) Om en ny körtel hos menniskan och åtskilliga däggdjur. Upsala Lakareforen Forh 15:441–471Google Scholar
  2. 2.
    Seipel CM (1938) An english translation of Sandström’s Glandulae Parathyreoideae. Bull Inst Hist Med 6:179–222Google Scholar
  3. 3.
    Owen R (1862) On the anatomy of the Indian rhinoceros. Trans Zool Soc Lond 4:31–58Google Scholar
  4. 4.
    Nordenström J (2013) The hunt for the parathyroids. Karolinska Institute University Press, StockholmGoogle Scholar
  5. 5.
    Boothby WM (1921) The parathyroid glands: a review of the literature. Endocrinology 5:403–440CrossRefGoogle Scholar
  6. 6.
    Baber EC (1881) Researches on the minute structure of the thyroid gland. Philos Trans 172:577–608CrossRefGoogle Scholar
  7. 7.
    Horsley V (1892) Remarks on the function of the thyroid gland: a critical historical review. Br Med J 1(215–219):265–268CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Gley E (1891) Sur les fonctions du corps thyroide. Comptes Rendus Soc Biol Paris 43:841–842Google Scholar
  9. 9.
    Gley E (1891) Sur la toxicité des urine des chiens thyroîdectomisés. Contribution a l’étude des fonctions du corps thyroïde. Comptes Rendus Soc Biol Paris 3:366–368Google Scholar
  10. 10.
    Vassale G, Generali F (1896) Sur les effets de l’extirpation des glandes parathyréoïdes. Arch Ital Biol 25:459–464Google Scholar
  11. 11.
    Vassale G, Generali F (1896) Fonction parathyroidienne et fonction thyroidienne. Arch Ital Biol 33:154–155Google Scholar
  12. 12.
    Erdheim J (1911) Über die Dentinverkalkung im Nagezahn bei der Epithelkörperchentransplantation. Frankfurt Z Pathol 7:295–347Google Scholar
  13. 13.
    MacCallum WG, Voegtlin C (1909) On the relation of tetany to the parathyroid glands and to calcium metabolism. J Exp Med 11:118–161CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    Parhon C, Urechie CS (1907) Untersuchungen über den Einfluss den die Calcium and Sodiumsalze auf den Verlauf der experimentellen Tetanie ausüben. Neurol Centralbl 26:1099Google Scholar
  15. 15.
    Koch WF (1913) Toxic bases in the urine of parathyroidectomized dogs. J Biol Chem 15:43–63Google Scholar
  16. 16.
    Koch WF (1915) The physiology of the parathyroid glands. J Labor Clin Med 1:299–315Google Scholar
  17. 17.
    Paton DN, Findlay L, Burns D (1914–1915) On guanidine or methylguanidine as a toxic agent in the tetany following parathyroidectomy. J Physiol 49:17–18Google Scholar
  18. 18.
    Collip JB (1925) The extraction of a parathyroid hormone which will prevent or control parathyroid tetany and which regulates the level of blood calcium. J Biol Chem 63:395–438Google Scholar
  19. 19.
    Collip JB, Leitch DB (1925) A case of tetany treated with parathyrin. Can Med Assoc J 15:59–60PubMedCentralPubMedGoogle Scholar
  20. 20.
    Hanson AM (1923) An elementary chemical study of the parathyroid glands of cattle. Mil Surg 53:280–284Google Scholar
  21. 21.
    Hanson AM (1924) Experiments with active preparations of parathyroid other than that of desiccated gland. Mil Surg 53:701–718Google Scholar
  22. 22.
    Albright F, Ellsworth R (1929) Studies on the physiology of the parathyroid glands: I. Calcium and phosphorus studies on a case of idiopathic hypoparathyroidism. J Clin Invest 7:183–201CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Albright F, Burnett CH, Smith PH (1942) Pseudo-hypoparathyroidism – an example of ‘Seabright-Bantam syndrome’: report of three cases. Endocrinology 30:922–932Google Scholar
  24. 24.
    Albright F, Forbes AP, Henneman PH (1952) Pseudo-pseudohypoparathyroidism. Trans Assoc Am Phys 65:337–350PubMedGoogle Scholar
  25. 25.
    Sanger F (1949) The terminal peptides of insulin. Biochem J 45:563–574PubMedCentralPubMedGoogle Scholar
  26. 26.
    Handler P, Cohn DU, Dratz AF (1954) Metabolic interrelations with special reference to calcium. In: 5th Josiah Macy conference. Progress Associated, Inc, New YorkGoogle Scholar
  27. 27.
    Aurbach GD (1959) Isolation of parathyroid hormone after extraction with phenol. J Biol Chem 234:3179–3181PubMedGoogle Scholar
  28. 28.
    Rasmussen H, Craig L (1959) Purification of parathyroid hormone by use of countercurrent distribution. J Am Chem Soc 81:5003CrossRefGoogle Scholar
  29. 29.
    Niall HD, Keutmann H, Sauer R, Hogan M, Dawson B, Aurbach G, Potts J Jr (1970) The amino acid sequence of bovine parathyroid hormone I. Hoppe Seylers Z Physiol Chem 351:1586–1588PubMedGoogle Scholar
  30. 30.
    Brewer HB Jr, Ronan R (1970) Bovine parathyroid hormone: amino acid sequence. Proc Natl Acad Sci U S A 67:1862–1869CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Keutmann HT, Sauer MM, Hendy GN, O’Riordan LH, Potts JT Jr (1978) Complete amino acid sequence of human parathyroid hormone. Biochemistry 17:5723–5729CrossRefPubMedGoogle Scholar
  32. 32.
    Potts JT Jr, Tregear GW, Keutmann HT, Niall HD, Sauer R, Deftos LJ, Dawson BF, Hogan ML, Aurbach GD (1971) Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc Natl Acad Sci U S A 68:63–67CrossRefPubMedCentralPubMedGoogle Scholar
  33. 33.
    Tregear GW, van Rietschoten J, Greene E, Niall HD, Keutmann HT, Parsons JA, O’Riordan JL, Potts JT Jr (1974) Solid-phase synthesis of the biologically active N-terminal 1–34 peptide of human parathyroid hormone. Hoppe Seylers Z Physiol Chem 355:415–421CrossRefPubMedGoogle Scholar
  34. 34.
    Ekins R (1980) More sensitive immunoassays. Nature 284:14–15CrossRefPubMedGoogle Scholar
  35. 35.
    Potts JT (2005) Parathyroid hormone: past and present. J Endocrinol 187:311–325CrossRefPubMedGoogle Scholar
  36. 36.
    Jüppner H, Potts JT Jr (2002) Immunoassays for the detection of parathyroid hormone. J Bone Miner Res 17(Suppl 2):N81–N86PubMedGoogle Scholar
  37. 37.
    Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT Jr, Segre GV (1987) Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364–1367PubMedGoogle Scholar
  38. 38.
    Jüppner H, Abou-Samra AB, Freeman M et al (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024–1026CrossRefPubMedGoogle Scholar
  39. 39.
    Gardella T, Jüppner H, Brown E, Kronenberg H, Potts J Jr (2010) Parathyroid hormone and parathyroid hormone -related peptide in the regulation of calcium homeostasis and bone regulation. In: DeGroot L, Jameson J (eds) Endocrinology, 6th edn. W. B. Saunders Co., PhiladelphiaGoogle Scholar
  40. 40.
    Thakker RV (2001) Genetic developments in hypoparathyroidism. Lancet 357:974–976CrossRefPubMedGoogle Scholar
  41. 41.
    Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, Rust N, Hobbs MR, Heath H 3rd, Thakker RV (2013) Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia. N Engl J Med 368:2476–2486CrossRefPubMedCentralPubMedGoogle Scholar
  42. 42.
    Mannstadt M, Harris M, Bravenboer B, Chitturi S, Dreijerink KM, Lambright DG, Lim ET, Daly MJ, Gabriel S, Jüppner H (2013) Germline mutations affecting Galpha11 in hypoparathyroidism. N Engl J Med 368:2532–2534CrossRefPubMedCentralPubMedGoogle Scholar
  43. 43.
    Maeda A, Okazaki M, Baron DM et al (2013) Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH. Proc Natl Acad Sci U S A 110:5864–5869CrossRefPubMedCentralPubMedGoogle Scholar
  44. 44.
    Mannstadt M, Clarke BL, Vokes T et al (2013) Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol 1:275–283CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2015

Authors and Affiliations

  1. 1.Endocrine UnitMassachusetts General Hospital, Harvard Medical SchoolBostonUSA
  2. 2.Clinical MedicineMassachusetts General HospitalBostonUSA

Personalised recommendations